hepatitis B vaccine (Vaxiva)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehepatitis B vaccine (Vaxiva)
Drug Alias NameN/A
ClassificationVaccines
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWorld
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVaxiva Biosciences KK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxiva Biosciences KK
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A